Jonathan H. Ryder, MD

This common skin and soft tissue infection has a high recurrence rate and significant treatment failure. β-Lactams remain effective first-line treatments, though rising resistance to clindamycin and tetracycline, especially in GAS, is a growing concern.

Changes in microbiology and antimicrobial resistance patterns warrant reevaluation of our current therapies for this condition.